Clarion Healthcare, LLC

Founded in 2003 by CEO Thomas Murtagh and MD Bart Lombardi by Dan Hawkins and based in Massachusetts, US, Clarion Healthcare, LLC is a life science strategy and organizational consultancy firm that provides insights and fit-for-purpose strategies. The company serves global and integrated pharmaceutical manufacturers, specialty pharmaceutical manufacturers, biotechnology firms, device and diagnostic companies, and venture capital, and private equity firms. In 2020, Svoboda Capital Partners, LLC recapitalized Clarion Healthcare, LLC and later Centerfield Capital Partners acquired the company. As of 2021, the company staffs over 70 employees.

The company holds expertise in cardiac diseases, Central Nervous System (CNS), digital therapeutics, dermatology, metabolic disorders, hepatology, and immunology among others. Clarion provides its services in three stages of value creation: Envision, Craft, and Enable and it includes market/landscape assessments, quantitative and qualitative research on patient journey and leverage points, scenario planning, early commercial business case, and therapeutic area strategy as well as competency assessments, business development, licensing assessments, and corporate strategy diagnostics. Additionally, Clarion provides product profiling, clinical development strategy, positioning and messaging platform, marketing strategy, market access strategy, and medical strategies as well as launch execution, business model designs, new enterprise scale-up, and commercial organizational design.